How much funding has Moleculent AB raised?

Moleculent AB has raised $46.0M in total funding, most recently a Series B round.

When was Moleculent AB founded?

Moleculent AB was founded in 2019.

Where is Moleculent AB headquartered?

Moleculent AB is headquartered in Solna, Sweden.

What industry is Moleculent AB in?

Moleculent AB operates in Biotech, Life Sciences.

How many employees does Moleculent AB have?

Moleculent AB has 11-50 employees.

Moleculent AB

Q: Who are Moleculent AB's investors?

Moleculent AB's investors include ARCH Venture Partners, Rubicon Healthcare Partners, EIR Ventures.

The Future of Cellular Understanding - Moleculent

Solna, Sweden · Founded 2019 · $46.0M raised

Biotech

Life Sciences

Headquarters: Solna
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: moleculent.com
Total Funding: $46.0M
Last Round: $20.0M Series BApr 2026
Rounds: 2

About

Moleculent is a Stockholm-area life sciences company founded in 2019 by Olle Ericsson, developing a functional biology platform that detects cell-cell interactions and receptor-ligand communication in native tissue context.

Summary

Moleculent AB is a Biotech company based in Solna, Sweden, founded in 2019. It has raised $46.0M in total across 2 rounds, most recently a $20.0M Series B round in Apr 2026. Investors include ARCH Venture Partners, Rubicon Healthcare Partners and EIR Ventures.

LinkedIn X (Twitter)